Rechallenge pemetrexed-based chemotherapy provides an option for initially benefited patients with advanced lung adenocarcinoma

por Wang, Jia-Ni, Qiao, Quan-Hui, Hu, Xing-Sheng, Liu, Yu-Tao, Wang, Zhi-Jie, Duan, Jian-Chun, Feng, Yu, Zhu, Hao-Hua
Publicado 2021